Jiang, Liewen
Agios Pharmaceuticals (United States)
2 papers on CoChat
Most cited papers
- Verified
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
Tap, W. D., Villalobos, V. M., Cote, G. M., Burris, H., Janku, F., Mir, O., Beeram, M., Wagner, A. J., Jiang, L., Wu, B., et al. (2020) · Journal of Clinical Oncology
Bone Tumor Diagnosis and TreatmentsSarcoma Diagnosis and Treatment
Cited by 165
- Verified
Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
Meyers, C. D., Tremblay, K., Amer, A., Chen, J., Jiang, L., & Gaudet, D. (2015) · Lipids in Health and Disease
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 110
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free